Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Manh-Cuong Vo

15 ta ish

Duy Tan University

AkademScholarda batafsil koʻrsatkichlar

  1. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model

    Jaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung‐Hoon Jung +12

    MaqolaOchiq kirish20213 iqtibos
    ABI

  2. Anti-BCMA Dual Epitope-Binding CAR-Marrow Infiltrating Lymphocytes (MILs) Could Offer a Potent Innovative Immunotherapeutic Tool Against Multiple Myeloma

    Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +6

    Maqola20232 iqtibos
    ABI

  3. Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma

    Thanh-Nhan Nguyen-Pham, Sung‐Hoon Jung, Manh-Cuong Vo +7

    Maqola20152 iqtibos
    ABI

  4. Immunotherapy for the treatment of multiple myeloma

    Sung‐Hoon Jung, Hyunju Lee, Manh-Cuong Vo +2

    Sharh maqola20172 iqtibos
    ABI

  5. Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

    Manh-Cuong Vo, Sung‐Hoon Jung, Tan-Huy Chu +6

    Maqola20182 iqtibos
    ABI

  6. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model

    Manh-Cuong Vo, Seoyun Yang, Sung‐Hoon Jung +6

    Maqola20182 iqtibos
    ABI

  7. Cellular immunotherapy in multiple myeloma

    Manh-Cuong Vo, Thangaraj Jaya Lakshmi, Sung‐Hoon Jung +7

    Sharh maqola20192 iqtibos
    ABI

  8. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

    Tan-Huy Chu, Manh-Cuong Vo, Hye-Seong Park +4

    Maqola20202 iqtibos
    ABI

  9. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21

    Jaya Lakshmi Thangaraj, Minh‐Trang Thi Phan, SoonHo Kweon +14

    Maqola20212 iqtibos
    ABI

  10. Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

    Tan-Huy Chu, Manh-Cuong Vo, Jaya Lakshmi Thangaraj +8

    Maqola20222 iqtibos
    ABI

  11. Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer

    Eun Kyung Jung, Tan-Huy Chu, Manh-Cuong Vo +10

    Maqola20222 iqtibos
    ABI

  12. Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

    Jaya Lakshmi Thangaraj, Sung‐Hoon Jung, Manh-Cuong Vo +11

    Maqola20222 iqtibos
    ABI

  13. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

    Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

    MaqolaOchiq kirishCAR-T cell therapy researchJournal of Hematology & Oncology20251 iqtibos
    ABI

  14. Exploring cellular immunotherapy platforms in multiple myeloma

    Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

    MaqolaOchiq kirishCAR-T cell therapy researchHeliyon20241 iqtibos
    ABI

  15. Exploring Cellular Immunotherapy Platforms in Multiple Myeloma

    Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

    PreprintCAR-T cell therapy researchSSRN Electronic Journal20230 iqtibos
    ABI